1. Complexities and Challenges of Non-Vaccine Methods for Infectious Disease Prevention
Vaccine and Infectious Disease Institute
Fred Hutchinson Cancer Research Center
January 14th, 2008.
Welcome
Thanks to Steve, Julie and Larry.
Today’s symposium divided into two sections; Looking first at issues in clinical trial research : trying to find things that work
Second looking at implementation and policy: once you’ve found something that works, what will it take to roll it out.

2. What's so hard about microbicides, anyway? Delivery, Timing and Type
Case Studies in HIV Prevention Trial Design
Analyzing Direct Effects in Randomized Trials with Secondary Interventions: Application to HIV Prevention Trials
Translating Prevention Strategies to Impact
Home-based HIV Counseling and Testing: Public Health Impact and Opportunities for Population Level Impact of HIV Prevention Strategies
Cervical cancer prevention in low-income countries: Is a comprehensive approach possible?
Criteria influencing potential impact of prevention interventions
Sharon Hillier, PhD U of Pittsburgh School of Medicine
Deborah Donnell, PhD, FHCRC
Michael Rosenblum, PhD, UC San Fran/UC Berkeley
Regina Rabinovich, MD, MPH, Bill and Melinda Gates Foundation
Jordan Tappero, MD, MPH, CDC Uganda
Vivien Tsu, PhD, MPH, PATH
Tom Fleming, PhD, University of Washington